- Home
- CHRS vs CHGG Comparison
CHRS vs CHGG Comparison
Compare CHRS & CHGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- CHGG
- Stock Information
- Founded
- CHRS 2010
- CHGG 2005
- Country
- CHRS United States
- CHGG United States
- Employees
- CHRS N/A
- CHGG N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- CHGG Other Consumer Services
- Sector
- CHRS Health Care
- CHGG Real Estate
- Exchange
- CHRS Nasdaq
- CHGG Nasdaq
- Market Cap
- CHRS 84.2M
- CHGG 149.2M
- IPO Year
- CHRS 2014
- CHGG 2013
- Fundamental
- Price
- CHRS $0.82
- CHGG $1.40
- Analyst Decision
- CHRS Buy
- CHGG Sell
- Analyst Count
- CHRS 3
- CHGG 7
- Target Price
- CHRS $4.68
- CHGG $1.70
- AVG Volume (30 Days)
- CHRS 1.3M
- CHGG 5.6M
- Earning Date
- CHRS 08-07-2025
- CHGG 08-04-2025
- Dividend Yield
- CHRS N/A
- CHGG N/A
- EPS Growth
- CHRS N/A
- CHGG N/A
- EPS
- CHRS N/A
- CHGG N/A
- Revenue
- CHRS $272,251,000.00
- CHGG $564,611,000.00
- Revenue This Year
- CHRS N/A
- CHGG N/A
- Revenue Next Year
- CHRS $106.56
- CHGG N/A
- P/E Ratio
- CHRS $1.87
- CHGG N/A
- Revenue Growth
- CHRS 19.87
- CHGG N/A
- 52 Week Low
- CHRS $0.66
- CHGG $0.44
- 52 Week High
- CHRS $2.43
- CHGG $3.81
- Technical
- Relative Strength Index (RSI)
- CHRS 53.13
- CHGG 58.00
- Support Level
- CHRS $0.72
- CHGG $1.14
- Resistance Level
- CHRS $0.77
- CHGG $1.40
- Average True Range (ATR)
- CHRS 0.04
- CHGG 0.12
- MACD
- CHRS 0.01
- CHGG -0.02
- Stochastic Oscillator
- CHRS 91.62
- CHGG 66.64
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.